PNC Financial Services Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364 | Buy |
401
+355
| +772% | +$322 | ﹤0.01% | 4724 |
|
|
2025
Q1 | $21 | Buy |
46
+38
| +475% | +$17 | ﹤0.01% | 4864 |
|
|
2024
Q4 | $4 | Buy |
+8
| New | +$4 | ﹤0.01% | 4775 |
|
|
2024
Q1 | – | Sell |
-180
| Closed | -$196 | – | 4764 |
|
|
2023
Q4 | $196 | Buy |
+180
| New | +$196 | ﹤0.01% | 4491 |
|
|
2020
Q3 | – | Sell |
-300
| Closed | – | – | 3982 |
|
|
2020
Q2 | $0 | Hold |
300
| – | – | ﹤0.01% | 3986 |
|
|
2020
Q1 | $0 | Hold |
300
| – | – | ﹤0.01% | 3980 |
|
|
2019
Q4 | $0 | Hold |
300
| – | – | ﹤0.01% | 4049 |
|
|
2019
Q3 | $0 | Sell |
300
-10
| -3% | – | ﹤0.01% | 4059 |
|
|
2019
Q2 | $0 | Buy |
310
+10
| +3% | – | ﹤0.01% | 4081 |
|
|
2019
Q1 | $0 | Hold |
300
| – | – | ﹤0.01% | 4084 |
|
|
2018
Q4 | $0 | Sell |
300
-43
| -13% | – | ﹤0.01% | 4112 |
|
|
2018
Q3 | $0 | Hold |
343
| – | – | ﹤0.01% | 4186 |
|
|
2018
Q2 | $0 | Hold |
343
| – | – | ﹤0.01% | 4212 |
|
|
2018
Q1 | $0 | Hold |
343
| – | – | ﹤0.01% | 4236 |
|
|
2017
Q4 | $0 | Hold |
343
| – | – | ﹤0.01% | 4193 |
|
|
2017
Q3 | $0 | Sell |
343
-91,440
| -100% | – | ﹤0.01% | 4187 |
|
|
2017
Q2 | $252K | Hold |
91,783
| – | – | ﹤0.01% | 2009 |
|
|
2017
Q1 | $278K | Hold |
91,783
| – | – | ﹤0.01% | 1947 |
|
|
2016
Q4 | $290K | Hold |
91,783
| – | – | ﹤0.01% | 1908 |
|
|
2016
Q3 | $314K | Hold |
91,783
| – | – | ﹤0.01% | 1831 |
|
|
2016
Q2 | $210K | Hold |
91,783
| – | – | ﹤0.01% | 2048 |
|
|
2016
Q1 | $230K | Sell |
91,783
-7,710
| -8% | -$19.3K | ﹤0.01% | 2018 |
|
|
2015
Q4 | $330K | Buy |
99,493
+12,390
| +14% | +$41.1K | ﹤0.01% | 1762 |
|
|
2015
Q3 | $210K | Buy |
87,103
+372
| +0.4% | +$897 | ﹤0.01% | 2084 |
|
|
2015
Q2 | $254K | Hold |
86,731
| – | – | ﹤0.01% | 2063 |
|
|
2015
Q1 | $348K | Buy |
86,731
+24,780
| +40% | +$99.4K | ﹤0.01% | 1877 |
|
|
2014
Q4 | $186K | Hold |
61,951
| – | – | ﹤0.01% | 2120 |
|
|
2014
Q3 | $158K | Buy |
+61,951
| New | +$158K | ﹤0.01% | 2133 |
|